Biomedical Sciences Graduate Program

Pharmacology Research Program

The Master of Science and Ph.D. degrees in Biomedical Sciences–Pharmacology provide substantial opportunity to conduct research in molecular targeting, drug design and drug delivery in developing new approaches to treat disease. The multidisciplinary program enrolls a select group of graduate students interested in research-based careers in pharmacology, and provides a balance of classroom and laboratory work involving faculty at NEOMED and Kent State University. Strong research focus exists in the areas of cardiovascular and metabolic diseases, neurodegenerative and blood brain barrier pharmacology. Interdisciplinary approaches to research and theoretical problems are strongly emphasized.

Faculty Researchers at NEOMED

Through the Biomedical Sciences-Pharmacology program, graduate students have the opportunity to work with one of the following faculty researchers at NEOMED:

Yeong-Renn Chen, Ph.D.

Oxygen free radicals, nitric oxide, oxidative postranslational modifications and mitochondrial biology in myocardial infarction.

More on Chen

John Y.L. Chiang, Ph.D.

Molecular cloning, expression and regulation of cytochrome P-450 genes; regulation of bile acid synthesis and cholesterol metabolism in the human liver.

More on Chiang

William Chilian, Ph.D., FAHA, FCVS

Angiogenesis, arteriogenesis, regulation of coronary blood flow, heart failure, stem cells, regenerative medicine.

More on Chilian

Altaf Darvesh, Ph.D.

Development of antioxidant and anti-inflammatory strategies for neoplastic an neurodegenerative diseases, as well as psychiatric disorders.

More on Darvesh

Vanessa Fitsanakis, Ph.D.

More on Fitsanakis

Sheila Fleming, Ph.D.

Parkinson’s disease, alpha-synuclein, motor and non-motor behavioral function.

More on Fleming

Tariq Haqqi, Ph.D.

More on Haqqi

Muhammad Hossain, D.V.M., Ph.D.

More on Hossain

Takhar Kasumov, Ph.D.

Mitochondrial function, lipoprotein metabolism, protein synthesis and degradation, metabolomics and proteomics.

More on Kasumov

Yoon-Kwang Lee, Ph.D.

Structure and regulation of nuclear hormone receptors.

More onLee

Priya Raman, Ph.D.

Cellular and molecular mechanisms underlying cardiovascular complications associated with diabetes and obesity; atherosclerosis; leptin; Thrombospondin-1.

More on Raman

Prabodh Sadana, Ph.D.

Hormonal regulation of lipid metabolism.

More on Sadana

Charles Thodeti, Ph.D., FAHA, FCVS

Mechanical control of integrin activation in capillary endothelial cells, signal transduction.

More on Thodeti

Liya Yin, M.D., Ph.D.

Lipid metabolism, atherosclerosis, regulation of coronary circulation, coronary collateral growth, stem cells in cardiovascular regeneration.

More on Yin

Min You, Ph.D.

More on You

Yanqiao Zhang, M.D.

Regulation of lipid and glucose metabolism under normal and disease conditions.

More on Zhang